Irinotecan Hydrochloide Injection
Product Images NDC 68001-480

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Irinotecan Hydrochloide (NDC 68001-480). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bluepoint Laboratories, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Irinotecan Inj 40mg Carton Label (Irinotecan Spl Carton 2 mL)

Packaging label for Irinotecan Hydrochloride Injection, USP 40 mg/2 mL (20 mg/mL), an intravenous injection by BluePoint Laboratories. The label includes handling warnings, storage instructions, and a note that the drug must be diluted before use. The product is for single-dose vial use and is identified as a cytotoxic agent. Manufacturer information is Gland Pharma Ltd, India.*

FDA Label Image

Irinotecan Inj 100mg/5ml Carton Label (Irinotecan Spl Carton 5 mL)

Packaging label for Irinotecan Hydrochloride Injection, USP 20 mg/mL (100 mg/5 mL) by BluePoint Laboratories. The label indicates it is a sterile, aqueous solution for intravenous use only and must be diluted before use. It is a single dose vial containing 5 mL. The label warns that the product is cytotoxic and provides storage instructions and manufacturer details, stating it is made in India by Gland Pharma Ltd.*

FDA Label Image

Irinotecan HCl Injection 40mg Lable (Irinotecan Spl Container 2 mL)

Label for Irinotecan Hydrochloride Injection, USP, 40 mg/2 mL (20 mg/mL) in a 2 mL single dose vial by BluePoint Laboratories. The label states it is for intravenous use only and must be diluted before use. It includes a caution that it is a cytotoxic agent, manufacturing details from Gland Pharma Ltd, India, and space for lot and expiration information.*

FDA Label Image

Irinotecan Inj 100mg/5ml Label (Irinotecan Spl Container 5 mL)

Label for Irinotecan Hydrochloride Injection, USP, 100 mg/5 mL (20 mg/mL) single dose vial by BluePoint Laboratories. The label indicates intravenous use, cytotoxic agent caution, storage instructions, manufacturer (Gland Pharma Ltd, India), and states the product is for intravenous use only and must be diluted before use. It includes NDC 68001-480-22 and barcode.*

FDA Label Image

Irinotecan-spl-figure-1 (Irinotecan Spl Figure 1)

A Kaplan-Meier survival curve figure comparing probability over months for two treatment groups: Irinotecan/5-FU/LV and 5-FU/LV alone. The x-axis shows time in months, and the y-axis shows survival probability. The plot indicates a statistical difference with p<0.05 by log-rank test.*

FDA Label Image

Irinotecan-spl-figure-2 (Irinotecan Spl Figure 2)

A Kaplan-Meier survival curve showing the probability of survival over 30 months for two groups: Irinotecan/5-FU/LV and 5-FU/LV. The vertical axis represents survival probability from 0 to 1, and the horizontal axis represents time in months. The Irinotecan/5-FU/LV group shows higher survival probability compared to the 5-FU/LV group, with a p-value less than 0.05 indicating statistical significance according to a log-rank test.*

FDA Label Image

Irinotecan-spl-figure-3 (Irinotecan Spl Figure 3)

A survival probability Kaplan-Meier curve comparing Irinotecan and Best Supportive Care (BSC) over a period of 21 months. The vertical axis shows probability from 0 to 1, and the horizontal axis represents months. The graph indicates higher survival probability over time for the Irinotecan group compared to the BSC group.*

FDA Label Image

Irinotecan-spl-figure-4 (Irinotecan Spl Figure 4)

A Kaplan-Meier survival curve graph comparing the probability of survival over 21 months between two treatments: Irinotecan and 5-FU. The x-axis represents months, and the y-axis represents survival probability. The graph includes median follow-up times and sample sizes for each treatment group. Statistical significance is indicated by a p-value of 0.035 using a log-rank test.*

FDA Label Image

Irinotecan-spl-structure (Irinotecan Spl Structure)

Chemical structure of Irinotecan Hydrochloride, depicted with annotations for HCl and 3 H2O groups. The structural formula shows the molecular arrangement of atoms and bonds relevant to the active ingredient.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.